IDO Inhibitors
A class of therapeutic agents designed to selectively inhibit indoleamine 2,3-dioxygenase (IDO), a key enzyme in the tryptophan-kynurenine metabolic pathway. By blocking IDO activity, these inhibitors help restore T-cell function and counteract immune suppression within the tumor microenvironment, making them promising candidates for cancer immunotherapy, particularly in combination with checkpoint inhibitors and other immunomodulatory therapies.
Similar Products: BET Bromodomain Inhibitors, Broad-Spectrum Inhibitors
